What is the Japan Tissue Engineering Co., Ltd. stock price forecast?

Japan Tissue Engineering Co., Ltd. is currently trading at ¥595. View real-time AI analysis on Alpha Lenz.

What is Japan Tissue Engineering Co., Ltd. insider trading activity?

View the latest insider trading data for Japan Tissue Engineering Co., Ltd. on Alpha Lenz.

What is Japan Tissue Engineering Co., Ltd.'s P/E ratio?

Japan Tissue Engineering Co., Ltd.'s P/E ratio is -94.6.

Japan Tissue Engineering Co., Ltd.

JPX · 7774

¥595+11(+1.88%)Market closed

Ask about Japan Tissue Engineering Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Japan Tissue Engineering Co., Ltd. trades at a P/E of -94.6 (undervalued) with modest ROE of -4.3%.”

Ask for details →

Company Overview

Japan Tissue Engineering Co., Ltd. is a biotechnology company specializing in regenerative medicine. Its primary function is to develop and commercialize tissue-engineered products, which play a critical role in the fields of medicine and surgical repair. The company's innovative products are designed to replace and regenerate human cells, tissues, or organs, thereby greatly enhancing recovery prospects and improving the overall quality of healthcare. Operating within the vibrant biotechnology sector, Japan Tissue Engineering Co., Ltd. contributes significantly to advances in medical technologies and treatments. Its leadership in regeneration technology reflects Japan's strong commitment to research and development in biomedicine. As one of the few companies at the forefront of tissue engineering, it plays a vital role in the global push towards enhanced medical outcomes through advanced biotechnology solutions.

CEOMr. Kazuto Yamada

Websitehttps://www.jpte.co.jp

SectorHealthcare

IndustryBiotechnology

Employees204

Company Statistics

FY 2025

Profile

¥24,162,920,845Market Cap

¥2,455,474,000Revenue

0.00Shares Out

204Employees

Margins

61.55%Gross

-3.25%EBITDA

-9.71%Operating

-9.55%Pre-Tax

-10.40%Net

Valuation

-94.64P/E

4.15P/B

9.84EV/Sales

-253.99EV/EBITDA

-99.75P/FCF

Growth (CAGR)

5.29%Rev 3Yr

1.23%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-3.78%ROA

-4.29%ROE

-3.53%ROIC

Financial Health

¥3,885,449,000Cash & Cash Equivalents

¥-3,197,495,000Net Debt

11.81%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Japan Tissue Engineering Co., Ltd. trades at a P/E of -94.6 (undervalued) with modest ROE of -4.3%.”

Ask for details →

Frequently Asked Questions

Japan Tissue Engineering Co., Ltd. (ticker: 7774) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 204 employees. Market cap is $24.2B.

The current price is 595 with a P/E ratio of -94.64x and P/B of 4.15x.

ROE is -4.29% and operating margin is -9.71%. Annual revenue is $2.5B.